vs

Side-by-side financial comparison of Inspire Medical Systems, Inc. (INSP) and Waystar Holding Corp. (WAY). Click either name above to swap in a different company.

Waystar Holding Corp. is the larger business by last-quarter revenue ($313.9M vs $204.6M, roughly 1.5× Inspire Medical Systems, Inc.). On growth, Waystar Holding Corp. posted the faster year-over-year revenue change (22.4% vs 1.6%). Over the past eight quarters, Waystar Holding Corp.'s revenue compounded faster (15.7% CAGR vs 2.2%).

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

Waystar Holding Corp is a leading provider of integrated healthcare payment and revenue cycle management solutions. It serves healthcare providers, health systems, and payers across the United States, offering tools that streamline billing, claims processing, patient payment collection, and revenue optimization to reduce administrative burdens and improve financial performance for healthcare organizations.

INSP vs WAY — Head-to-Head

Bigger by revenue
WAY
WAY
1.5× larger
WAY
$313.9M
$204.6M
INSP
Growing faster (revenue YoY)
WAY
WAY
+20.8% gap
WAY
22.4%
1.6%
INSP
Faster 2-yr revenue CAGR
WAY
WAY
Annualised
WAY
15.7%
2.2%
INSP

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
INSP
INSP
WAY
WAY
Revenue
$204.6M
$313.9M
Net Profit
$43.3M
Gross Margin
86.5%
Operating Margin
13.0%
25.6%
Net Margin
13.8%
Revenue YoY
1.6%
22.4%
Net Profit YoY
47.9%
EPS (diluted)
$-0.39
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSP
INSP
WAY
WAY
Q1 26
$204.6M
$313.9M
Q4 25
$269.1M
$303.5M
Q3 25
$224.5M
$268.7M
Q2 25
$217.1M
$270.7M
Q1 25
$201.3M
$256.4M
Q4 24
$239.7M
$244.1M
Q3 24
$203.2M
$240.1M
Q2 24
$195.9M
$234.5M
Net Profit
INSP
INSP
WAY
WAY
Q1 26
$43.3M
Q4 25
$136.1M
$20.0M
Q3 25
$9.9M
$30.6M
Q2 25
$-3.6M
$32.2M
Q1 25
$3.0M
$29.3M
Q4 24
$35.2M
$19.1M
Q3 24
$18.5M
$5.4M
Q2 24
$9.8M
$-27.7M
Gross Margin
INSP
INSP
WAY
WAY
Q1 26
86.5%
Q4 25
86.6%
Q3 25
85.8%
Q2 25
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
84.1%
Q2 24
84.8%
Operating Margin
INSP
INSP
WAY
WAY
Q1 26
13.0%
25.6%
Q4 25
17.1%
19.4%
Q3 25
4.3%
22.4%
Q2 25
-1.5%
24.0%
Q1 25
-0.7%
25.4%
Q4 24
13.3%
21.8%
Q3 24
7.0%
11.3%
Q2 24
2.6%
3.5%
Net Margin
INSP
INSP
WAY
WAY
Q1 26
13.8%
Q4 25
50.6%
6.6%
Q3 25
4.4%
11.4%
Q2 25
-1.7%
11.9%
Q1 25
1.5%
11.4%
Q4 24
14.7%
7.8%
Q3 24
9.1%
2.3%
Q2 24
5.0%
-11.8%
EPS (diluted)
INSP
INSP
WAY
WAY
Q1 26
$-0.39
$0.42
Q4 25
$4.57
$0.10
Q3 25
$0.34
$0.17
Q2 25
$-0.12
$0.18
Q1 25
$0.10
$0.16
Q4 24
$1.17
$0.18
Q3 24
$0.60
$0.03
Q2 24
$0.32
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSP
INSP
WAY
WAY
Cash + ST InvestmentsLiquidity on hand
$98.9M
$34.3M
Total DebtLower is stronger
$13.5M
Stockholders' EquityBook value
$792.3M
$3.9B
Total Assets
$911.4M
$5.8B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSP
INSP
WAY
WAY
Q1 26
$98.9M
$34.3M
Q4 25
$308.3M
$61.4M
Q3 25
$322.6M
$421.1M
Q2 25
$300.9M
$290.3M
Q1 25
$369.2M
$224.0M
Q4 24
$445.5M
$182.1M
Q3 24
$411.0M
$127.1M
Q2 24
$439.7M
$68.4M
Total Debt
INSP
INSP
WAY
WAY
Q1 26
$13.5M
Q4 25
$1.5B
Q3 25
Q2 25
Q1 25
Q4 24
$1.2B
Q3 24
Q2 24
Stockholders' Equity
INSP
INSP
WAY
WAY
Q1 26
$792.3M
$3.9B
Q4 25
$781.2M
$3.9B
Q3 25
$666.5M
$3.2B
Q2 25
$677.8M
$3.2B
Q1 25
$635.7M
$3.1B
Q4 24
$689.7M
$3.1B
Q3 24
$696.6M
$3.1B
Q2 24
$638.1M
$2.9B
Total Assets
INSP
INSP
WAY
WAY
Q1 26
$911.4M
$5.8B
Q4 25
$907.3M
$5.8B
Q3 25
$807.7M
$4.7B
Q2 25
$802.2M
$4.7B
Q1 25
$730.8M
$4.6B
Q4 24
$808.4M
$4.6B
Q3 24
$796.2M
$4.5B
Q2 24
$728.4M
$4.6B
Debt / Equity
INSP
INSP
WAY
WAY
Q1 26
0.00×
Q4 25
0.38×
Q3 25
Q2 25
Q1 25
Q4 24
0.40×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSP
INSP
WAY
WAY
Operating Cash FlowLast quarter
$84.9M
Free Cash FlowOCF − Capex
$90.3M
FCF MarginFCF / Revenue
28.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.96×
TTM Free Cash FlowTrailing 4 quarters
$314.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSP
INSP
WAY
WAY
Q1 26
$84.9M
Q4 25
$52.5M
$66.6M
Q3 25
$68.5M
$82.0M
Q2 25
$2.7M
$96.8M
Q1 25
$-6.7M
$64.2M
Q4 24
$69.2M
Q3 24
$52.3M
$78.8M
Q2 24
$-78.0K
$15.4M
Free Cash Flow
INSP
INSP
WAY
WAY
Q1 26
$90.3M
Q4 25
$41.8M
$57.2M
Q3 25
$58.1M
$76.2M
Q2 25
$-6.3M
$91.0M
Q1 25
$-15.1M
$58.8M
Q4 24
$62.2M
Q3 24
$44.3M
$70.2M
Q2 24
$-12.5M
$8.6M
FCF Margin
INSP
INSP
WAY
WAY
Q1 26
28.8%
Q4 25
15.5%
18.9%
Q3 25
25.9%
28.3%
Q2 25
-2.9%
33.6%
Q1 25
-7.5%
22.9%
Q4 24
25.9%
Q3 24
21.8%
29.2%
Q2 24
-6.4%
3.7%
Capex Intensity
INSP
INSP
WAY
WAY
Q1 26
Q4 25
4.0%
3.1%
Q3 25
4.6%
2.2%
Q2 25
4.1%
2.1%
Q1 25
4.2%
2.1%
Q4 24
2.9%
Q3 24
3.9%
3.6%
Q2 24
6.3%
2.9%
Cash Conversion
INSP
INSP
WAY
WAY
Q1 26
1.96×
Q4 25
0.39×
3.33×
Q3 25
6.90×
2.68×
Q2 25
3.01×
Q1 25
-2.24×
2.20×
Q4 24
1.96×
Q3 24
2.83×
14.56×
Q2 24
-0.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INSP
INSP

Segment breakdown not available.

WAY
WAY

Subscription$172.2M55%
Volume-based$139.5M44%

Related Comparisons